We demonstrated that targeting the interaction between immunosuppressive CAFs and TAMs in the tolerogenic TME by OV-CXCR4-A induces tumor/self-specific CD8+ T cell responses that participate in tumor control. Here, CXCR4 is linked to neoplasm.